scorecardresearch
Wednesday, July 23, 2025
TopicPfizer

Topic: Pfizer

Pfizer, Moderna Covid vaccines 90% effective after 2 doses in ‘real-world’ use: US Study

According to data from US Centers for Disease Control & Prevention, Pfizer & Moderna Covid vaccines effectively prevented infections, not just illness, with substantial protection.

Around 2% of those given Pfizer, Moderna vaccines reported mild allergic reactions: Study

According to the Boston-based study on health care workers, those that did report an adverse reaction recovered without major treatment.

Pfizer-BioNTech vaccine neutralises Brazilian Covid strain in lab experiments

While the research, performed by University of Texas Medical Branch in Galveston, needs to be validated with real-world data, it offers another reason for optimism.

Israel finds Pfizer 75% effective, Hong Kong’s burner phone surge & other global Covid news

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe.

India ‘pharmacy to world’ but sector is fragmented, unorganised — foreign firms’ lobby says

Report highlights loopholes in distribution chain of pharma products, but also stresses on India’s important role in ‘promoting local and global health goals’.

Why India’s expert panel rejected Pfizer plea for emergency use nod to its Covid vaccine

The Drug Controller General of India has in the past rejected several applications from other drugmakers, including Dr Reddy Laboratory and Natco Pharma.

Pfizer-BioNTech vaccine could foil the UK Covid strain, new study shows

The results published Wednesday showed that antibodies in the blood of people who had been vaccinated were able to neutralize a version of the mutant virus that was created in the lab.

Pfizer to deliver fewer Covid vaccine doses in next 3-4 weeks as it renovates Belgium factory

The renovations will serve to boost capacity from mid-February, according to statements from Norway, Germany and the company.

Pfizer says couldn’t attend Modi govt meetings on its vaccine due to ‘extremely’ short notices

The US pharma firm is in the process of compiling responses to queries raised by Drugs Controller General of India on its vaccine data, says a Pfizer spokesperson.

Pfizer, BioNTech boost their Covid vaccine goal for 2021 to 2 billion doses

More than 50% boost from previous 2021 target of 1.3 billion doses, the increase incorporates a label change that will allow doctors to extract 6 doses instead of 5 from each vaccine vial.

On Camera

Pakistani accomplices, shootouts, sealed chargesheet—how the 7/11 blasts case fell apart

After 19 years, the Bombay High Court finally held what governments and intelligence services have long known: The men sentenced for their role in the bombings had nothing to do with it.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Indian firm sets up titanium, superalloy plants to meet global need. Safran, Dassault, BAE line up

PTC Industries is investing Rs 1,000 cr in 4 manufacturing plants in UP, has already started supplying titanium parts to BAE Systems for its M-777 howitzers that India also uses.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.